IGEA Pharma NV
SIX:IGPH

Watchlist Manager
IGEA Pharma NV Logo
IGEA Pharma NV
SIX:IGPH
Watchlist
Price: 0.0005 CHF Market Closed
Market Cap: 505.5k CHF

IGEA Pharma NV
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

IGEA Pharma NV
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
IGEA Pharma NV
SIX:IGPH
Free Cash Flow
-€401.2k
CAGR 3-Years
36%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
O
ONWARD Medical NV
XBRU:ONWD
Free Cash Flow
-€32.2m
CAGR 3-Years
-13%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

IGEA Pharma NV
Glance View

Market Cap
505.5k CHF
Industry
Health Care

IGEA Pharma NV is a health-tech company focused on measure and control of test factors related to life-threatening diseases. The company is headquartered in Hoofddorp, Noord-Holland. The company went IPO on 2018-12-20. The firm focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The firm develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer’s disease. The firm offers its services in the Netherlands.

IGPH Intrinsic Value
Not Available

See Also

What is IGEA Pharma NV's Free Cash Flow?
Free Cash Flow
-401.2k EUR

Based on the financial report for Dec 31, 2022, IGEA Pharma NV's Free Cash Flow amounts to -401.2k EUR.

What is IGEA Pharma NV's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-7%

Over the last year, the Free Cash Flow growth was 63%. The average annual Free Cash Flow growth rates for IGEA Pharma NV have been 36% over the past three years , -7% over the past five years .

Back to Top